Latest from David Allen
Emerging Strategies for Drug-Product Comparability and Process Validation: Part 2 — Validation, Legacy Products, and Lifecycle Management![](https://eu-images.contentstack.com/v3/assets/blt0a48a1f3edca9eb0/blt95255918b69dd9f7/658c057473c31d040ae57ffc/19-4-CMCForum-Part2-P1.jpg?width=700&auto=webp&quality=80&disable=upscale)
CMC Forums![](https://eu-images.contentstack.com/v3/assets/blt0a48a1f3edca9eb0/blt95255918b69dd9f7/658c057473c31d040ae57ffc/19-4-CMCForum-Part2-P1.jpg?width=700&auto=webp&quality=80&disable=upscale)
Emerging Strategies for Drug Product Comparability and Process Validation: Part 1 — Analytical Tools and Drug Product Comparability![](https://eu-images.contentstack.com/v3/assets/blt0a48a1f3edca9eb0/bltca5db13e17c16672/658c05e2da750b040ae28167/19-3-CMC-Forum-P1.png?width=700&auto=webp&quality=80&disable=upscale)
CMC Forums![](https://eu-images.contentstack.com/v3/assets/blt0a48a1f3edca9eb0/bltca5db13e17c16672/658c05e2da750b040ae28167/19-3-CMC-Forum-P1.png?width=700&auto=webp&quality=80&disable=upscale)
Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.